Regulation of CD40 function by its isoforms generated through alternative splicing
AUTOR(ES)
Tone, Masahide
FONTE
The National Academy of Sciences
RESUMO
CD40 is a member of the tumor necrosis factor receptor superfamily. The interaction between CD40 and CD40 ligand (CD154) activates NF-κB, Jun N-terminal kinase, and Janus kinase/signal transducers and activators of transcription pathways and promotes B cell growth, differentiation, and survival as well as IL-12 production in macrophages and dendritic cells. We demonstrate here the existence of multiple isoforms of CD40 mRNA generated by alternative splicing and show that their expression is regulated differentially in activated macrophages and dendritic cells. Pre-CD40 RNA is spliced preferentially out to signal-transducible CD40 mRNA in the early stage of activation; half of the CD40 mRNA is replaced by the signal-nontransducible CD40 mRNAs in the later stages (24 h). Using IL-12 p40 gene expression as a reporter for CD40 signaling, we show that three of the alternative isoforms can disable signaling through CD40. The major alternative isoform lacks the membrane-associated endodomain and seems to reduce the amount of the signal-transducible form available on the cell surface. It would seem, therefore, that CD40 expression is controlled by posttranscriptional and posttranslational regulation through alternative splicing. Modulation of isoform expression may provide a mechanism by which cells regulate their susceptibility to CD40L signaling.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=29329Documentos Relacionados
- Multiple Oct2 isoforms are generated by alternative splicing.
- Multiple Oct2 isoforms are generated by alternative splicing
- Alternative splicing generates secretory isoforms of human CD1.
- Drosophila and human RecQ5 exist in different isoforms generated by alternative splicing.
- Regulation of alternative splicing in the generation of isoforms of the mouse Ly-5 (CD45) glycoprotein.